• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Primary care new bag structure Jackie Nelson video

Observation: we are working our butts off trying to squeeze blood from a turnip, the pipeline is thin for at least a year, to few targeted hcps to maintain the required 10 cpd; our stock is rising?

Official communication: Back to teams organized by letters with two teams per manager, 4 reps with identical territories, rest assured we will maintain the same staffing

Speculation: Is the handwriting on the wall?

Maybe they are lining us up this way to make it easy for a future layoff.